Revitacare
Revitacare is a French specialty aesthetics laboratory founded in 2003 that designs, manufactures, and distributes hyaluronic acid-based Class III injectable Medical Devices, sterile cosmetics, and at-home skincare to medical doctors, beauticians, and consumers across 66 countries, and is owned by Bloomage BioTechnology since 2017.
- Company typePrivate
- Founded2003
- HeadquartersSaint-ouen-l'aumone, France
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Revitacare does
Laboratoire Revitacare (legal entity SAS REVITACARE) is a French private specialty aesthetics laboratory founded in 2003 by Martine Buzon and headquartered in Saint-Ouen-l'Aumône, France. The company researches, designs, manufactures, and distributes hyaluronic acid-based injectable Class III Medical Devices and sterile cosmetics under the CYTOCARE, HAIRCARE, REVITAFILL, and C Line brands, with a portfolio of 25 products covering facial rejuvenation, scalp and hair restoration, body contouring, and at-home skincare. Core technology centers on cross-linked and non-cross-linked hyaluronic acid formulations combined with proprietary nutrient complexes — CT50 (50 ingredients), RHB, CT43, CT5, CELLUCARE, and Micro-nutrient — produced under EN ISO 13485:2016 for medical devices and EN ISO 22716:2008 for cosmetics, with all injectable devices CE Marked under Council Directive 93/42/EEC. The BoxAuth QR-code authentication system, deployed since 2016, addresses counterfeit risk across professional channels.
The company operates a channel-led go-to-market: Class III injectables are sold to Medical Doctors (general practitioners, aesthetic doctors, plastic surgeons, dermatologists), sterile cosmetics are sold to beauticians and medical spas, and the 2022-launched CYTOCARE PARIS consumer skincare range extends the brand into at-home retail through medical and beauty intermediaries. Distribution runs through a network of partners spanning 66 countries, supplemented by 35 annual congress participations, a LinkedIn/Instagram/Facebook presence, the Revitacare Academy training platform, and a YouTube channel for procedure education. Pricing is quote-based and not publicly disclosed; revenue streams are transactional product sales across the three product tiers.
Since 2017, Revitacare has operated as part of Bloomage BioTechnology Corporation, the global leader in hyaluronic acid manufacturing, which secures raw material supply and augments R&D capacity. The company is led by CEO Chen Feng, with founder Martine Buzon's "Beauty starts with skin quality" philosophy still anchoring product strategy, and General Manager Jim Buzon representing the firm at international congresses. Headcount is 51–100 employees; revenue is not publicly disclosed.
Revitacare firmographics
Firmographics- Name
- Revitacare
- Legal name
- SAS REVITACARE
- Website
- https://revitacare.net
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Revitacare is a French specialty aesthetics laboratory founded in 2003 that designs, manufactures, and distributes hyaluronic acid-based Class III injectable Medical Devices, sterile cosmetics, and at-home skincare to medical doctors, beauticians, and consumers across 66 countries, and is owned by Bloomage BioTechnology since 2017.
- Ownership category
- akta.pro rank
Revitacare industry classification
Industry- Product category
- Aesthetic Medicine / Medical Devices
- NAICS
- Toilet Preparation Manufacturing (32562), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
- akta.pro secondary industries
- Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK), Body Skincare (Lotions, Creams, Body Oils) (CRABAAAD)
Keywords
Where Revitacare is headquartered
LocationHeadquarters
- HQ city
- Saint-ouen-l'aumone
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Revitacare business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel
Revenue model
- Medical Devices Sales: Sale of Class III injectable Medical Devices (CYTOCARE 502-516-532, CYTOCARE S Line, HAIRCARE, REVITAFILL Essential 1-2-3-4) to Medical Doctors for aesthetic procedures. Products are distributed through global network of distribution partners in 66 countries.
- Sterile Cosmetics Sales: Sale of C Line Sterile Cosmetics (CYTOCARE 516-532 C Line, CYTOCARE 640 C Line, CYTOCARE 715 C Line, CELLUCARE C Line, STRETCHCARE C Line, HAIRCARE C Line) to Beauticians, Aesthetic Professionals, and Medical Spa centers.
- Home Skincare Products: Sale of CYTOCARE PARIS cosmetic skincare range for at-home use, distributed through Medical Doctors and Beauty Professionals including Beauty salons and Medical aesthetic clinics.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Revitacare product offering
Product offeringCore offering
Laboratoire Revitacare researches, designs, manufactures, and distributes hyaluronic acid-based injectable Medical Devices (Class III) for skin quality improvement, dermal filling, and hair restoration, as well as Sterile Cosmetics for professional beauty treatments and CYTOCARE PARIS consumer skincare. Products are sold through a global distribution partner network spanning 66 countries.
Product overview
Laboratoire Revitacare is a French pioneer in Aesthetic Medicine founded in 2003, specializing in research, design, manufacture, and distribution of hyaluronic acid-based products. The company operates a three-tier product portfolio: (1) Class III Medical Devices for Medical Doctors including injectable resorbable implants (CYTOCARE 502/516/532, CYTOCARE S Line, HAIRCARE) and cross-linked dermal fillers (REVITAFILL Essential 1-4); (2) Sterile Cosmetics under the C Line brand for Beauticians and aesthetic professionals, covering face, neck, décolleté, body, and scalp care (CYTOCARE 516-532/640/715 C Line, CELLUCARE C Line, STRETCHCARE C Line, HAIRCARE C Line); and (3) CYTOCARE PARIS consumer cosmetics for at-home skincare. All products are manufactured under EN ISO 13485:2016 and EN ISO 22716:2008 standards, with the company operating in 66 countries through global distribution partners.
Differentiator
Problem solved
Functional benefit
Brands
- CYTOCARE PARIS: First hyaluronic acid cosmetic skincare range for face at home, inspired by professional formulas. Distributed in France and internationally through Medical Doctors and Beauty Professionals.
- CYTOCARE
- HAIRCARE
- REVITAFILL
- C Line
Products and services
- CYTOCARE 502-516-532 Range of resorbable injectable implants composed of non-cross-linked hyaluronic acid combined with CT50 Rejuvenating Complex (vitamins, amino acids, minerals), for improving skin quality through micro-injections into superficial and medium dermis. Used by Medical Doctors for skin rejuvenation.
- CYTOCARE S Line Resorbable injectable implant composed of hyaluronic acid plus Rejuvenating Complex, for peri-orbital and perioral lines (vertical lip lines), delivered via micro-injections into superficial and medium dermis for advanced skin types.
- HAIRCARE (Medical Device) Resorbable injectable implant containing hyaluronic acid 2mg plus Restructuring Hair Complex (vitamins, minerals), for micro-injections into dermis of the scalp near hair roots to improve hair quality, restore hydration, and reduce hair loss.
- REVITAFILL Essential 1-2-3-4 Range of four said-biphasic cross-linked hyaluronic acid dermal fillers (20mg/mL) with different particle sizes, dispersed in physiological buffer, for volume enhancement and correction of facial defects, wrinkles, and scars. Class III Medical Devices.
- CYTOCARE 516-532 C Line Sterile cosmetic solution with hyaluronic acid and Age Defying CT43 complex for face application, providing smoothing effect and improving complexion radiance. For topical use with micro-current and plasmaporation technologies by beauticians.
- CYTOCARE 640 C Line Hydrating and smoothing sterile cosmetic solution with hyaluronic acid for face, neck, and décolleté, improving skin suppleness and radiance. Suitable for micro-current and plasmaporation technologies.
- CYTOCARE 715 C Line Anti-aging sterile cosmetic solution with hyaluronic acid, Carnosine, and Amino Acids Complex for plumping effect, luminous complexion, and reduction of fine lines and wrinkles.
- CELLUCARE C Line Anti-cellulite sterile cosmetic with firming and smoothing effects, containing hyaluronic acid plus Nutrients Complex with Caffeine, Manganese, and Zinc for body application (arms, stomach, knees, thighs).
- STRETCHCARE C Line Toning sterile cosmetic solution with tightening effect, containing hyaluronic acid plus Micro-nutrient Complex (DMAE and Vitamin B5) for face and body to improve skin elasticity.
- HAIRCARE C Line Scalp care sterile cosmetic with hyaluronic acid and Restructuring Complex, soothing, hydrating scalp, reducing dandruff visibility, and strengthening hair.
- CYTOCARE PARIS First hyaluronic acid cosmetic skincare range for face at-home use, inspired by professional formulas. Distributed by Medical Doctors and Beauty Professionals including beauty salons, medical aesthetic clinics, and medical spa centers. Contains CT5 complex with Ectoin, Niacinamide, Anigozanthos Flavidus extract, Leontopodium Alpinium extract, and Carnosine.
Quantifiable outcome
- 100% of satisfaction questionnaire respondents reported hair loss is slowed down with HAIRCARE C Line (use test on 23 volunteers over 28 days)
- +3 more outcomes
Companies that use Revitacare
Customer profileSegments3 records
Ideal customer profiles3 records
Revitacare technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Revitacare partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Bloomage BioTechnology CorporationcoreIn 2017, Laboratoire Revitacare joined Bloomage BioTechnology Corporation, the worldwide leader in hyaluronic acid manufacturing. This strategic incorporation enables Revitacare to increase its Research & Development capabilities to develop new products. Bloomage provides high-quality hyaluronic acid to prestigious luxury brands globally and is striving to become a leader in high-quality development of life sciences. The partnership provides Revitacare with secured supply of pharmaceutical-grade hyaluronic acid raw materials.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Revitacare competitors and assessment
Company assessmentDirect peers
- Croma-Pharma: Austrian manufacturer of hyaluronic acid-based aesthetic injectables (Princess filler range) and ophthalmology products. Mid-sized European peer competing in the same Class III HA-injectable + professional aesthetics categories.
- IBSA Derma: Swiss specialty pharma behind Profhilo, a cross-linked HA injectable for skin bio-remodeling. A focused direct peer in injectable HA-based skin-quality treatments, distributed through physicians and aesthetic clinics.
- Mesoestetic Pharma Group: Spanish pharmaceutical group focused on aesthetic medicine, offering mesotherapy solutions, cosmeceuticals, and professional devices. A mid-sized European peer with a similar medical-grade aesthetic product portfolio and distribution through clinics.
- Teoxane Laboratories: Swiss-based maker of injectable hyaluronic acid dermal fillers (Teosyal RHA range) and cosmeceuticals. Closest direct competitor to Revitacare: same HA injectable + sterile cosmetic + professional skincare model, sold through physicians and aesthetic clinics across Europe and internationally.
Broad incumbents
- Merz Aesthetics: Specialty aesthetics arm of Merz Group behind Belotero hyaluronic acid fillers, Radiesse biostimulator, and Ultherapy. Directly competes with Revitacare in injectable HA-based skin rejuvenation sold through dermatologists and plastic surgeons.
- Galderma: Global dermatology-focused company behind the Restylane HA injectable franchise and Skinboosters. A dominant incumbent in the same injectable HA + skin-quality segment Revitacare competes in, though operating at significantly larger scale.
- AbbVie (Allergan Aesthetics): Owner of the Juvéderm and Skinvive HA injectable franchises. Competes with Revitacare in the same injectable aesthetic medicine space and benefits from far deeper sales/marketing resources and cross-sell into medical aesthetics.
- Filorga Laboratoires: French-origin dermo-cosmetics brand now owned by Colgate-Palmolive, offering professional skincare (NCTF mesotherapy) and consumer anti-aging lines. Highly comparable business model: medical-aesthetic heritage extended into a consumer skincare range, like CYTOCARE PARIS.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Revitacare social profiles
Digital presenceRevitacare compliance and trust
Trust signalCompliance5 records
Revitacare financial estimates
Financial estimateRevenue estimate
Valuation estimate
Revitacare leadership team
Management profileNumber of profiles
Profiles2 records
Revitacare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Revitacare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Revitacare
What does Revitacare do?
Laboratoire Revitacare researches, designs, manufactures, and distributes hyaluronic acid-based injectable Medical Devices (Class III) for skin quality improvement, dermal filling, and hair restoration, as well as Sterile Cosmetics for professional beauty treatments and CYTOCARE PARIS consumer skincare. Products are sold through a global distribution partner network spanning 66 countries.
Is Revitacare a public or private company?
Revitacare is a private company. It is classified as corporate owned and is currently operating.
When was Revitacare founded?
Revitacare was founded in 2003. It employs 51 to 100 people.
Where is Revitacare based?
Revitacare is headquartered in Saint-ouen-l'aumone, France, in the Europe region.
How does Revitacare make money?
Three revenue lines are on record. Medical Devices Sales are the primary driver. The others are sterile Cosmetics Sales and home Skincare Products.
Who are Revitacare's main competitors?
Direct peers on record are Croma-Pharma, IBSA Derma, Mesoestetic Pharma Group and Teoxane Laboratories. Broad incumbents are Merz Aesthetics, Galderma, AbbVie (Allergan Aesthetics) and Filorga Laboratoires.
Does Revitacare have an API?
No public API is recorded for Revitacare.
What industry is Revitacare in?
Revitacare's product category is Aesthetic Medicine / Medical Devices. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of CRABAAAK, Professional/Backbar Skincare (Esthetician & Spa Use). Its NAICS code is 32562 and its SIC code is 2844.